ARCHIVES

OCC to Take Over CIS Oct; Cost Sharing “Is Dead”

This article is from The Cancer Letter archive.

Vol. 14 No. 29 | July 15, 1988

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

March 31, 1989

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

November 18, 2011

NCCS Networker Volume 4 Issue 1, Winter 1990

January 13, 1990

Researchers Find Genetic Alterations in Triple-Negative Cancers Following Treatment

January 25, 2013

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013

DCE Concepts Approved

June 27, 1986